anti-GM-CSF mAb (Amgen)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-GM-CSF mAb (Amgen)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionMacrophage colony stimulating factor 2 inhibitors

TargetsMacrophage colony stimulating factor 2

Therapy Area/IndicationsMultiple Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsMultiple Sclerosis

ATC CodeN/A